 |
PDBsum entry 4cfk
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The commonly used pi3-Kinase probe ly294002 is an inhibitor of bet bromodomains.
|
 |
|
Authors
|
 |
A.Dittmann,
T.Werner,
C.W.Chung,
M.M.Savitski,
M.Fälth savitski,
P.Grandi,
C.Hopf,
M.Lindon,
G.Neubauer,
R.K.Prinjha,
M.Bantscheff,
G.Drewes.
|
 |
|
Ref.
|
 |
Acs Chem Biol, 2014,
9,
495-502.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
A commonly used small-molecule probe in cell-signaling research is the
phosphoinositide 3-kinase inhibitor LY294002. Quantitative chemoproteomic
profiling shows that LY294002 and LY303511, a close analogue devoid of PI3K
activity, inhibit the BET bromodomain proteins BRD2, BRD3, and BRD4 that
comprise a family of targets structurally unrelated to PI3K. Both compounds
competitively inhibit acetyl-lysine binding of the first but not the second
bromodomain of BET proteins in cell extracts. X-ray crystallography shows that
the chromen-4-one scaffold represents a new bromodomain pharmacophore and
establishes LY294002 as a dual kinase and BET-bromodomain inhibitor, whereas
LY303511 exhibits anti-inflammatory and antiproliferative effects similar to the
recently discovered BET inhibitors.
|
 |
|
|
|
|
 |